News From Former Members

Jennifer's research involved developing a method for phosphopeptide analysis using Capillary Electrophoresis (CE) and Electrospray Ionization Mass Spectrometry (ESI-MS).

She is currently the Owner of Jennifer Ballard Photography in Toronto.

Heidi's research involved a novel approach to developing a potent inhibitor of the human peptidyl-prolyl isomerase Pin1.

She is currently working in Dr. Hunter and Dr. Goldberg's laboratory in the Dental Science building on campus.

Larry's work involved implementing the lab's new IonSpec QFT-12 FT-ICR for use in a variety of proteomics-based projects..

Currently he is working at MDS Sciex in Conchord Ontario.

Dustin's research involved the syntheses of novel peptides with antimicrobial / antimycotic properties.

He is currently attending Dental school at UBC.

Greg Vilk, Ph.D. (Biochemistry)
Post Doctoral Fellow

Greg's research focused on the proteomic investigation of the effects of anti-fungal peptides on medically–important yeasts such as Candida albicans.

Greg is currently working in the laboratory of Dr. David White at the Robarts Research Institute.

Aaron Booy, M.Sc. (Biochemistry)

Aaron's research involved the discovery of candidate protein biomarkers for the disease, preeclampsia.

He is currently working at MDS Sciex.

Research Technician (Bioinformatics)

czhang2@uwo.ca

Cunjie joined Prof. Lajoie's team as a Research Technician in 2002.  In September 2005, she accepted the position of Manager of the Functional Proteomics Facility under the direction of Professor David Litchfield.  Cunjie can still be found much of the time in the Lajoie lab.

Research Technician

Helen purified peptides and prepared DNA constructs.

Mark's research involved the synthesis of novel short cyclic peptides

He is currently working at Merck Frosst in Montreal.

Mandana studied phosphorylation of rat bone osteopontin using mass spectrometry.

She is currently working as a mass spectrometry technician at Eli Lilly & Co. in Indianapolis, IN.

Sibylle studied potential binding targets of histatin 5 (H5) in Saccharomyces cerevisiae.

She is currently pursuing a Ph.D. at the School of Pharmacy, University of London.